The healthcare data annotation market is estimated to be at $1.58 billion in 2024, and projected to reach $32.26 billion by the end of 2037. The rapid adoption of machine learning and AI for diagnostic support, especially in medical imaging (such as X-rays and MRI scans), propels this market.
The rise in automated tools that aid in tasks like early diagnosis and robotic surgery also contributes significantly to its expansion. Precise annotation enables AI to predict disease progression, personalize treatments, and accelerate drug development, improving patient outcomes. Let's explore where artificial intelligence is most used in medicine, and dive into the intricacies of medical annotation using the Keymakr experience.
